Cargando…

The Immune Subtype Contributes to Distinct Overall Survival for Ovarian Cancer Patients With Platinum-Based Adjuvant Therapy

OBJECTIVE: Nowadays, platinum-based therapy has been widely used as the first-line therapy of ovarian cancer. However, the effect of the tumor microenvironment on platinum-based therapy remains unclear. In this study, we aim to investigate the relationship between immune microenvironment subtypes an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yueyi, Wang, Hang, Chen, Ming, Ma, Xuelei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263722/ https://www.ncbi.nlm.nih.gov/pubmed/35812434 http://dx.doi.org/10.3389/fimmu.2022.872991

Ejemplares similares

Distinct Stromal and Immune Features Collectively Contribute to Long-Term Survival in Pancreatic Cancer
por: Sadozai, Hassan, et al.
Publicado: (2021)

Immune landscape of distinct subtypes in urothelial carcinoma based on immune gene profile
por: Peng, Mou
Publicado: (2022)

Overall Survival and Adjuvant Therapy in Women with Ovarian Carcinosarcoma: A Single-Institution Experience
por: Nizam, Aaron, et al.
Publicado: (2019)

Tumor Size and Overall Survival in Patients With Platinum-Resistant Ovarian Cancer Treated With Chemotherapy and Bevacizumab
por: Sostelly, Alexandre, et al.
Publicado: (2019)

Distinct subtypes of endometriosis identified based on stromal-immune microenvironment and gene expression: implications for hormone therapy
por: Wang, Yuning, et al.
Publicado: (2023)

The role of cancer-associated mesothelial cells in the progression and therapy of ovarian cancer
por: Zheng, Aiping, et al.
Publicado: (2022)

Infiltration by CXCL10 Secreting Macrophages Is Associated With Antitumor Immunity and Response to Therapy in Ovarian Cancer Subtypes
por: Ardighieri, Laura, et al.
Publicado: (2021)

Evaluating distinct KRAS subtypes as potential biomarkers for immune checkpoint inhibitor efficacy in lung adenocarcinoma
por: Wang, Qi, et al.
Publicado: (2023)

Calpain-2 expression is associated with response to platinum based chemotherapy, progression-free and overall survival in ovarian cancer
por: Storr, Sarah J, et al.
Publicado: (2012)

A TP53-Associated Immune Prognostic Signature for the Prediction of Overall Survival and Therapeutic Responses in Muscle-Invasive Bladder Cancer
por: Wu, Xiangkun, et al.
Publicado: (2020)

Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant
por: Yang, Chang, et al.
Publicado: (2020)

Unsupervised Clustering Reveals Distinct Subtypes of Biliary Atresia Based on Immune Cell Types and Gene Expression
por: Pang, Xiuqing, et al.
Publicado: (2021)

Editorial: Community series in immunotherapy with checkpoint inhibitors for non-small cell lung cancer, colon cancer, and esophageal cancer, volume II
por: Li, Yueyi, et al.
Publicado: (2023)

Prediction of risk and overall survival of pancreatic cancer from blood soluble immune checkpoint-related proteins
por: Pan, Sai, et al.
Publicado: (2023)

Therapeutic implications of the tumor microenvironment in ovarian cancer patients receiving PD-1/PD-L1 therapy
por: Wang, Yusha, et al.
Publicado: (2022)

Recognition of Tumor-Associated Antigens and Immune Subtypes in Glioma for mRNA Vaccine Development
por: Ma, Shuai, et al.
Publicado: (2021)

Immune Cell Subtypes and Their Function in the Testis
por: Bhushan, Sudhanshu, et al.
Publicado: (2020)

Nomograms Predicting Platinum Sensitivity, Progression-Free Survival, and Overall Survival Using Pretreatment Complete Blood Cell Counts in Epithelial Ovarian Cancer
por: Paik, E Sun, et al.
Publicado: (2017)

Immune Microenvironment in Glioblastoma Subtypes
por: Chen, Zhihong, et al.
Publicado: (2018)

Immune Subtyping in Latent Tuberculosis
por: Banerjee, Ushashi, et al.
Publicado: (2021)

An Immune Cell Signature Is Associated With Disease-Free Survival and Adjuvant Chemosensitivity of Patients With Resectable Gastric Cancer
por: Yan, Hongfei, et al.
Publicado: (2021)

Preliminary Safety and Potential Effect of 6B11-OCIK Adoptive Cell Therapy Against Platinum-Resistant Recurrent or Refractory Ovarian Cancer
por: Cheng, Hongyan, et al.
Publicado: (2021)

Distinct molecular subtypes of systemic sclerosis and gene signature with diagnostic capability
por: Wang, Qi, et al.
Publicado: (2023)

Signatures of Multi-Omics Reveal Distinct Tumor Immune Microenvironment Contributing to Immunotherapy in Lung Adenocarcinoma
por: Huang, Ziqi, et al.
Publicado: (2021)

Crosstalk of RNA Adenosine Modification-Related Subtypes, Establishment of a Prognostic Model, and Immune Infiltration Characteristics in Ovarian Cancer
por: Ni, Xiaoge, et al.
Publicado: (2022)

Colorectal Cancer-Associated Immune Exhaustion Involves T and B Lymphocytes and Conventional NK Cells and Correlates With a Shorter Overall Survival
por: Sorrentino, Carlo, et al.
Publicado: (2021)

An immune-related gene pairs signature predicts overall survival in serous ovarian carcinoma
por: Zhang, Liuyan, et al.
Publicado: (2019)

Global Transcriptomics Uncovers Distinct Contributions From Splicing Regulatory Proteins to the Macrophage Innate Immune Response
por: Wagner, Allison R., et al.
Publicado: (2021)

Double Insurance for OC: miRNA-Mediated Platinum Resistance and Immune Escape
por: Zou, Xueqin, et al.
Publicado: (2021)

Peripheral blood CD3+HLADR+ cells and associated gut microbiome species predict response and overall survival to immune checkpoint blockade
por: Gorgulho, Joao, et al.
Publicado: (2023)

A panel of three oxidative stress-related genes predicts overall survival in ovarian cancer patients received platinum-based chemotherapy
por: Zhang, Jin, et al.
Publicado: (2018)

Esthesioneuroblastoma: Summary of Single-center Experiences with Focus on Adjuvant Therapy and Overall Survival
por: Alotaibi, Hammam A, et al.
Publicado: (2019)

Evaluating relapse-free survival as an endpoint for overall survival in adjuvant immunotherapy trials
por: Li, Yuanfang, et al.
Publicado: (2023)

Unique profile on the progress free survival and overall survival in patients with advanced non-small cell lung cancer in the Qujing area, Southwest China
por: Ma, Yuhui, et al.
Publicado: (2023)

A Comparative Phase I Study of Combination, Homologous Subtype-C DNA, MVA, and Env gp140 Protein/Adjuvant HIV Vaccines in Two Immunization Regimes
por: Joseph, Sarah, et al.
Publicado: (2017)

AS03-Adjuvanted, Very-Low-Dose Influenza Vaccines Induce Distinctive Immune Responses Compared to Unadjuvanted High-Dose Vaccines in BALB/c Mice
por: Yam, Karen K., et al.
Publicado: (2015)

No Overall Survival Difference in the Immunotherapy Era for Rare Subtypes of Melanoma
por: Safi, Mohammed, et al.
Publicado: (2021)

Immune Subtypes in LUAD Identify Novel Tumor Microenvironment Profiles With Prognostic and Therapeutic Implications
por: Wang, Feng, et al.
Publicado: (2022)

The prognostic effect of sixteen malnutrition/inflammation-based indicators on the overall survival of chemotherapy patients
por: Liu, Tong, et al.
Publicado: (2023)

A comparative study of adjuvants effects on neonatal plasma cell survival niche in bone marrow and persistence of humoral immune responses
por: Aradottir Pind, Audur Anna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_oaqcrjp0sqdf1u38ohd0g2gtff